3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
6
Neoplasms
5
Breast Neoplasms
3
Testicular Neoplasms
2
Polycystic Ovary Syndrome
2
Sleep Apnea, Obstructive
1
Sleep Apnea Syndromes
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Obesity
1
Neoplasm Metastasis
1
Muscle Weakness
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Metabolic Syndrome
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Infertility
1
Hypogonadism
1
Hot Flashes
1
Fatigue
1
Dyspareunia
1
Arthralgia
1
Interventions
Metformin
2
Ethinyl Estradiol
2
Blood Pressure
2
drospirenone and ethinyl estradiol combination
1
drospirenone
1
Vascular Stiffness
1
Ultrasonography
1
Triptorelin Pamoate
1
Testosterone
1
Sugars
1
Spironolactone
1
Pulse Wave Analysis
1
Preoperative Exercise
1
Phlebotomy
1
Orchiectomy
1
Medical History Taking
1
Magnetic Resonance Spectroscopy
1
Inositol
1
Human Growth Hormone
1
Hematologic Tests
1
Growth Hormone
1
Flutamide
1
Exercise
1
Etanercept
1
Electrocardiography
1
Echocardiography
1
Diet, Reducing
1
Diet, Mediterranean
1
Diet, Fat-Restricted
1
Diet Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Metabolic Syndrome
×
Testosterone
×
Clear all
NCT02991209
2020-03-06
Einstein
Rigshospitalet, Denmark
Phase 2/3
Completed
69 enrolled